Prestige Brands Holdings, Inc. to Release Fiscal 2015 Second Quarter Earnings on November 6th

Prestige Brands Holdings, Inc. (NYSE:PBH) today announced that it will issue its fiscal 2015 second quarter earnings release on Thursday, November 6, 2014 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. EST.

To access the call, listeners calling from within North America may dial 877-280-4954 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 857-244-7311. The conference passcode is “prestige”. The Company will provide a live Internet web cast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 888-286-8010 within North America, and at 617-801-6888 from outside North America. The passcode is 87362413.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the United States and Canada, and in certain international markets. Core brands include Monistat® yeast infection treatment, Nix® lice treatment, Chloraseptic® sore throat treatments, Compound W® wart treatments, Clear Eyes® eye care products, Little Remedies® and PediaCare® pediatric over-the-counter healthcare products, The Doctor’s® NightGuard® dental protector, Efferdent® denture care products, Luden’s® throat drops, Dramamine® motion sickness treatment, BC® and Goody’s® headache remedies, Beano® gas prevention, Debrox® earwax remover, and in Canada, Gaviscon® antacid.